2018 Update and 2019 Outlook Given at the CPHI Conference

  • Estelle® Oral Contraception programme on track – US/CANADA Phase III arm due to complete in Q4 2018; partnering discussions ongoing including for us market
  • Preparations for Phase III Donesta® trials moving ahead, including co-partnering discussions
  • Further Marketing authorisations obtained for MyRing™

Liège, Belgium, 10 October 2018 – 20:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, provided an update on its key programmes at the CPHI world conference.